Funds and ETFs Catalent, Inc.

Equities

CTLT

US1488061029

Pharmaceuticals

Market Closed - Nyse 21:00:02 14/05/2024 BST 5-day change 1st Jan Change
55.52 USD -0.50% Intraday chart for Catalent, Inc. -1.79% +23.57%

ETFs positioned on Catalent, Inc.

Name Weight AuM 1st Jan change Investor Rating
0.03% 6 M€ +17.98% -
0.03% 121 M€ +7.29% -
0.02% 34 M€ +11.81% -
0.02% 786 M€ -.--%
0.02% 23 M€ -.--% -
0.02% 571 M€ +7.35% -
0.02% 34 M€ +8.28% -
0.02% 1,487 M€ +7.21% -
0.02% 284 M€ -.--%
0.02% 14 M€ +16.19% -
0.02% 206 M€ -.--%
0.02% 306 M€ +5.95% -
0.02% 39 M€ +5.31% -
0.02% 273 M€ -.--%
0.02% 1,174 M€ +23.54%
0.02% 655 M€ -.--% -
0.01% 17 M€ +2.84% -
0.01% 607 M€ +0.05% -
0.01% 1,166 M€ +0.26% -
0.01% 391 M€ +8.80% -
0.01% 1 M€ -.--%
0.01% 45 M€ 0.00% -
0.01% 9 M€ +9.94% -
0.01% 8 M€ +0.60% -
0.01% 17 M€ +4.20% -
0.01% 105 M€ +3.54% -
0.01% 29 M€ -.--% -
0.01% 322 M€ +13.88% -
Catalent, Inc. is specialized in pharmaceutical outsourcing services. The group offers solutions for the development and formulation of drugs, biological products and animal health products. Net sales break down by activity as follows: - provision of development services and clinical supply services (55.4%); - subcontracted manufacturing services (44.6%). Net sales are distributed geographically as follows: the United States (63.2%), Europe (28.7%) and other (8.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
55.52 USD
Average target price
63.5 USD
Spread / Average Target
+14.37%
Consensus
  1. Stock Market
  2. Equities
  3. CTLT Stock
  4. Funds and ETFs Catalent, Inc.